VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | 0.0% | 53 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | -75.0% | 53 | -57.6% | 0.00% | -66.7% |
| Q4 2021 | $4,000 | 0.0% | 125 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | -42.9% | 125 | -42.1% | 0.00% | -40.0% |
| Q2 2021 | $7,000 | 0.0% | 216 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $7,000 | -12.5% | 216 | 0.0% | 0.01% | -25.0% |
| Q4 2020 | $8,000 | -11.1% | 216 | -56.8% | 0.01% | +33.3% |
| Q3 2018 | $9,000 | -82.4% | 500 | -78.3% | 0.01% | -83.8% |
| Q2 2018 | $51,000 | 0.0% | 2,300 | 0.0% | 0.04% | -5.1% |
| Q1 2018 | $51,000 | -5.6% | 2,300 | 0.0% | 0.04% | -2.5% |
| Q4 2017 | $54,000 | – | 2,300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |